Policy
Harnessing the COVID-19 Response Towards Hepatitis C Elimination
Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network
Resources search
Filter
Displaying 1 - 12 of 821
-
-
Data
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study
Li X et al. The Lancet -
Sub-national plans
United States National Perinatal Hepatitis B Prevention Program: 2009–2017
Koneru A et al. Pediatrics -
Data
Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study
Dugan E at al. Lancet Gastroenterol Hepatol -
Guidelines
AASLD Expert Panel Consensus Statement: Vaccines to Prevent COVID-19 Infection in Patients with Liver Disease
American Association for the Study of Liver Diseases (AASLD) -
Program evaluation
Accelerating access to hepatitis C diagnostics and treatment: Overcoming barriers in low- and middle-income countries
World Health Organization -
Health economics
Integrated approach for triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis is highly effective and cost-effective: an economic evaluation
Zhang L et al. International Journal of Epidemiology -
Policy
Regional Framework for The Triple Elimination of MTCT of HIV, HBV, and Syphilis in the Asia and the Pacific, 2018-2030
World Health Organization WPRO Regional Office -
Guidelines
Analyzing and using routine data to monitor the effects of COVID-19 on essential health services: Practical guidance for national and sub-national decision-makers
World Health Organization -
Program evaluation
Initial success from a public health approach to hepatitis C testing, treatment and cure in seven countries: the road to elimination
Clinton Health Access Initiative -
Data
Impact of COVID-19 on Global Elimination: African Region
-
Data
Impact of COVID-19 on Global Elimination: European Region